Conference: What future for Biotech and MedTech in the Covid-19 era?

The co-founders of the companies Theranexus and VitaDX will host the next HEC Challenge + club conference on the theme "What future for Biotechs and MedTech in the Covid-19 era", on Tuesday 19 May, at 2 p.m. , remotely and in French.

What future for Biotech and MedTech in the Covid-19 era? The example of VitaDX and Theranexus.

It's the new HEC Challenge Plus club conference! It will take place on May 19th, at 2pm, online, and will be hosted by Franck Mouthon, co-founder and CEO of THERANEXUS & Allan Rodriguez, co-founder and CEO of VitaDX (HEC Challenge + winners). They will answer, among others, the following questions:

• Scientific and economic specificities of biotech and MedTech startups
• What are the therapeutic prospects and health challenges for the next decade?
• Feedback on the creation and development of VitaDX and Theranexus.
• The role of Venture Capital and the Stock Exchange in the development of the Biotech and MedTechs industry.

Information: delombre@hec.fr